These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16179504)

  • 21. Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome.
    Brouns R; Sheorajpanday R; Kunnen J; De Surgeloose D; De Deyn PP
    Eur Neurol; 2009; 62(1):9-15. PubMed ID: 19407450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome.
    Vibo R; Kõrv J; Roose M; Kampus P; Muda P; Zilmer K; Zilmer M
    Free Radic Res; 2007 Mar; 41(3):282-7. PubMed ID: 17364956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT dispersion in patients with acute ischemic stroke who underwent thrombolytic treatment: is it really useful to predict good neuorologic recovery?
    Celik T; Iyisoy A; Bugan B; Isik E
    Int J Cardiol; 2008 Apr; 125(2):290-1. PubMed ID: 18190979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging the future of stroke: I. Ischemia.
    Liebeskind DS
    Ann Neurol; 2009 Nov; 66(5):574-90. PubMed ID: 19938071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid analysis in the diagnosis and treatment of arterial ischemic stroke.
    Riou EM; Amlie-Lefond C; Echenne B; Farmer M; Sébire G
    Pediatr Neurol; 2008 Jan; 38(1):1-9. PubMed ID: 18054685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recanalization after thrombolysis in stroke patients: predictors and prognostic implications.
    Zangerle A; Kiechl S; Spiegel M; Furtner M; Knoflach M; Werner P; Mair A; Wille G; Schmidauer C; Gautsch K; Gotwald T; Felber S; Poewe W; Willeit J
    Neurology; 2007 Jan; 68(1):39-44. PubMed ID: 17200490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory markers for ischaemic stroke.
    Pola R
    Thromb Haemost; 2009 May; 101(5):800-1. PubMed ID: 19404529
    [No Abstract]   [Full Text] [Related]  

  • 28. Xenon techniques in predicting patients at risk for stroke after balloon test occlusion.
    Carlson A; Yonas H
    Neurosurgery; 2009 Jun; 64(6):E1206. PubMed ID: 19487869
    [No Abstract]   [Full Text] [Related]  

  • 29. Predicting stroke outcome: what does the 'stroke prognostocrit level' indicate?
    Sacco RL
    Nat Clin Pract Neurol; 2006 Nov; 2(11):577. PubMed ID: 17057738
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of magnetic resonance angiography to predict long-term outcomes of ischemic stroke patients with concurrent stenoses in Hong Kong.
    Man BL; Fu YP; Chan YY; Lam W; Hui CF; Leung WH; Wong KS
    Cerebrovasc Dis; 2009; 28(2):112-8. PubMed ID: 19506369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the Triage Stroke Panel in a neurologic emergency service.
    Sibon I; Rouanet F; Meissner W; Orgogozo JM
    Am J Emerg Med; 2009 Jun; 27(5):558-62. PubMed ID: 19497461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project.
    Di Carlo A; Lamassa M; Baldereschi M; Pracucci G; Consoli D; Wolfe CD; Giroud M; Rudd A; Burger I; Ghetti A; Inzitari D;
    J Neurol Sci; 2006 May; 244(1-2):143-50. PubMed ID: 16530226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
    Rallidis LS; Vikelis M; Panagiotakos DB; Liakos GK; Krania E; Kremastinos DT
    Acta Neurol Scand; 2008 Jun; 117(6):415-20. PubMed ID: 18093263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility and clinical relevance of quantitative EEG parameters in cerebral ischemia: a basic approach.
    Sheorajpanday RV; Nagels G; Weeren AJ; van Putten MJ; De Deyn PP
    Clin Neurophysiol; 2009 May; 120(5):845-55. PubMed ID: 19375386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke.
    Wunderlich MT; Lins H; Skalej M; Wallesch CW; Goertler M
    Clin Neurol Neurosurg; 2006 Sep; 108(6):558-63. PubMed ID: 16457947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premorbid antiplatelet use and ischemic stroke outcomes.
    Li HF; Pan XD
    Neurology; 2006 Nov; 67(9):1723; author reply 1723. PubMed ID: 17101925
    [No Abstract]   [Full Text] [Related]  

  • 37. Symptomatic autoregulatory failure in acute ischemic stroke.
    Zazulia AR; Videen TO; Powers WJ
    Neurology; 2007 Jan; 68(5):389-90. PubMed ID: 17261690
    [No Abstract]   [Full Text] [Related]  

  • 38. Relevance of neuroimaging in the evaluation of cerebral ischemia.
    Fazekas F; Niederkorn K; Ebner F; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():1-8. PubMed ID: 19342828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum lipid levels and 3-month prognosis in Chinese patients with acute stroke.
    Li W; Liu M; Wu B; Liu H; Wang LC; Tan S
    Adv Ther; 2008 Apr; 25(4):329-41. PubMed ID: 18414815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperresponsiveness of platelets in ischemic stroke.
    Fateh-Moghadam S; Htun P; Tomandl B; Sander D; Stellos K; Geisler T; Langer H; Walton K; Handschu R; Garlichs C; Daniel WG; Gawaz M
    Thromb Haemost; 2007 Jun; 97(6):974-8. PubMed ID: 17549300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.